- 英文名称
- Picroside I
- 分子式
- C24H28O11
- 分子量
- 492.47
- 中文别名
- 胡黄连苷 I; 胡黄连甙I; 胡黄连苦苷I; ((2R,3S,4S,5R,6S)-3,4,5-三羟基-6-(((1aS,1bS,2S,5aR,6S,6aS)-6-羟基-1a-(羟甲基)-1a,1b,2,5a,6,6a-六氢环氧乙烷并[2',3':4,5]环戊二烯并[1,2-c]吡喃-2-基)氧基)四氢-2H-吡喃-2-基)甲基 肉桂酸酯; picroside i; picroside-1; PicrosideI; 6'-O-trans-cinnamoylcatalpol; (1aS,1bS,2S,5aR,6S,6aS)-6-Hydroxy-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl 6-O-[(2E)-3-phenyl-2-propenoyl]-β-D-glucopyranoside; picrosides I; (1aS,1bS,2S,5aR,6S,6aS)-2-(β-D-Glucopyranosyloxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-6-yl (2E)-3-phenylacrylate; ((2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(((1aS,1bS,2S,5aR,6S,6aS)-6-hydroxy-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[2',3':4,5]cyclopenta[1,2-c]pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methyl cinnamate; beta-d-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-(3-phenyl-2-propenoate), [1aS-[1aalpha,1bbeta,2beta(E),5abeta,6beta,6aalpha]]-; Picroside-Ⅰ; 6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl,6-(3-phenyl-2-propenoate), [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα]]-; β-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-; [1aS-[1aalpha,1bbeta,2beta(E),5abeta,6beta,6aalpha]]-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl 6-(3-phenyl-2-propenoate) beta-D-glucopyranoside; β-d-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-(3-phenyl-2-propenoate), [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα]]-
- 用途
- Picroside I 是胡黄连的主要成分，可用于含量测定/鉴定/药理实验等；具有保肝降酶、利胆退黄、免疫调节、抗乙肝病毒作用，可用于哮喘研究，能显著减轻炎症，下调 pSTAT6 和 GATA3 表达，剂量依赖性增加血清 IFN-γ 水平。
